Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to determine the efficacy of once-daily rosuvastatin in reducing LDL-C in children and adolescents aged 10-17 years with HeFH from baseline (Day 0) to the end of...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AstraZeneca
NCT07473960 · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
NCT07489209 · Homozygous Familial Hypercholesterolemia (HoFH)
NCT07037771 · Homozygous Familial Hypercholesterolemia
NCT07058077 · Heterozygous Familial Hypercholesterolemia (HeFH)
NCT06331195 · Familial Hypercholesterolemia
Research Site
Los Angeles, California
Research Site
Hyde Park, New York
Research Site
Cincinnati, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions